4 – Alzheimers

Elan Corp. Plc and Transition Therapeutics Inc. said Tuesday they’ve eliminated two of three doses used in a mid-stage study of a potential Alzheimer’s disease treatment after nine patients died while receiving the higher doses.

Read more:
Alzheimer’s drug trial altered after 9 deaths (AP via Yahoo! News)

Tags: three-doses, receiving-the-higher, TUESDAY, alzheimer, corp-, mid-stage-study, higher, while-receiving

Related posts:

1. Transition falls after deaths in Alzheimer’s drug study (MalaysiaNews.net)
2. Pfizer Alzheimer’s disease drug fails in study (AP via Yahoo! News)
3. Alzheimer’s drug Dimebon helps Huntington’s: study (Reuters via Yahoo! News)
4. Brain images suggest Alzheimer’s drug is working (Reuters via Yahoo! News)
5. Sea Squirt Helps Researchers Test New Alzheimer’s Drug (HealthDay via Yahoo! News)

This entry was posted on Tuesday, December 15th, 2009 at 7:31 pm and is filed under Alzheimer's Disease. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.